Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hummel

Showing results (361-370 of 385) with videos related to

Pageof 39
Sort By:
Leukemia|June 23, 2019
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGSHenrik Knecht, Tomas Reigl, Michaela Kotrová, et al.
Blood|January 9, 2014
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphomaItziar Salaverria, Idoia Martin-Guerrero, Rabea Wagener, et al.
Cancers|July 14, 2023
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical ValidationEva-Maria Willing, Claudia Vollbrecht, Christine Vössing, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Leukemia|June 28, 2019
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation studyMonika Brüggemann, Michaela Kotrová, Henrik Knecht, et al.
Genes, Chromosomes & Cancer|April 7, 2025
Subtyping Burkitt Lymphoma by DNA MethylationSelina Glaser, Rabea Wagener, Helene Kretzmer, et al.
Blood Advances|April 23, 2026
DNA methylation-based classification of hematolymphoid neoplasmsAnnapurna Saksena, Christin Siewert, Rust Turakulov, et al.
BMC Medical Genetics|July 16, 2014
Role of estrogen related receptor beta (ESRRB) in DFN35B hearing impairment and dental decayMegan L Weber, Hong-Yuan Hsin, Ersan Kalay, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2015
MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cellsGero Doose, Andrea Haake, Stephan H Bernhart, et al.
Pageof 39

Showing results (361-370 of 385) with videos related to

Sort By:
Pageof 39
Leukemia|June 23, 2019
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGSHenrik Knecht, Tomas Reigl, Michaela Kotrová, et al.
Blood|January 9, 2014
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphomaItziar Salaverria, Idoia Martin-Guerrero, Rabea Wagener, et al.
Cancers|July 14, 2023
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical ValidationEva-Maria Willing, Claudia Vollbrecht, Christine Vössing, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Leukemia|June 28, 2019
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation studyMonika Brüggemann, Michaela Kotrová, Henrik Knecht, et al.
Genes, Chromosomes & Cancer|April 7, 2025
Subtyping Burkitt Lymphoma by DNA MethylationSelina Glaser, Rabea Wagener, Helene Kretzmer, et al.
Blood Advances|April 23, 2026
DNA methylation-based classification of hematolymphoid neoplasmsAnnapurna Saksena, Christin Siewert, Rust Turakulov, et al.
BMC Medical Genetics|July 16, 2014
Role of estrogen related receptor beta (ESRRB) in DFN35B hearing impairment and dental decayMegan L Weber, Hong-Yuan Hsin, Ersan Kalay, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2015
MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cellsGero Doose, Andrea Haake, Stephan H Bernhart, et al.
Pageof 39